Medtronic, Inc.

Michael Jay Ebert

Gabriela C Molnar

Richard T Stone

Eric H Bonde

Erik R Scott

John E Kast

Phillip C Falkner

Randy S Roles

Xuan K Wei

Brad Conrad Tischendorf

Todd V Smith

Shawn C Kelley

Anthony M Chasensky

Kenneth E Cobian

John Louis Sommer

Jennifer P Miller

Craig L Schmidt

Christian S Nielsen

Gordon Orvis Munns

Rick D McVenes

Bernard Q Li

Thomas P Miltich

Chris J Paidosh

Joseph J Viavattine

Reginald D Robinson

Prabhakar A Tamirisa

Markus W Reiterer

Richard Dean Ries

Mark T Stewart

Timothy J Denison

David A Dinsmoor

Amy E Thompson-Nauman

Duane L Bourget

Joel A Anderson

Forrest C M Pape

Nathan A Grenz

Pedro A Meregotte

Stephen J Roddy

Mark J Paulsen

James R Keogh

Kenneth B Stokes

Michael D Eggen

Allan H Jevne

Paul C Slaikeu

Kenneth R Brennen

Richard L Molacek

David Wayne Bourn

James M Anderson

Jordan D Honeck

Christopher M Hobot

Zhongping C Yang

Terrell M Williams

Steven Lawrence Waldhauser

Douglas N Hess

Jordon D Honeck

David W Mayer

Gabriela C Miyazawa

Peter B McIntyre

Joseph J Klein

Gregory P Shipe

Mark D Schneider

James H Vaughan

Stanton D Myrum

A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.

Minimally invasive implantable neurostimulation system

A medical device system for delivering a neuromodulation therapy includes a delivery tool for deploying an implantable medical device at a neuromodulation therapy site. The implantable medical device includes a housing, an electronic circuit within the housing, and an electrical lead comprising a lead body extending between a proximal end coupled to the housing and a distal end extending away from the housing and at least one electrode carried by the lead body. The delivery tool includes a first cavity for receiving the housing and a second cavity for receiving the lead. The first cavity and the second cavity are in direct communication for receiving and deploying the housing and the lead coupled to the housing concomitantly as a single unit.

A method and medical device for monitoring patient medication compliance that includes a plurality of electrodes to deliver a pacing therapy and a processor configured to determine a pacing threshold in response to the delivered pacing therapy, determine whether there is a change in the pacing threshold, and determine patient medication compliance in response to the determined changes.

Method and apparatus for monitoring of patient medication compliance

A method and medical device for monitoring cardiac function in a patient that includes a plurality of electrodes to deliver cardiac pacing therapy, and a processor configured to determine a pacing threshold in response to initial delivery of the pacing therapy, determine whether there is a change in the pacing threshold during initial delivery of the pacing therapy, adjust a delivery parameter of the pacing therapy in response to determining the change in the pacing threshold during initial delivery of the pacing therapy, determine whether there is an increase in the pacing threshold during delivery of the adjusted pacing therapy, and determine hypokalemia in response to the increase in the pacing threshold during delivery of the adjusted pacing therapy being present.

Method and apparatus for cardiac function monitoring

A method and medical device for monitoring cardiac function in a patient that includes a plurality of electrodes to deliver cardiac pacing therapy, and a processor configured to determine a pacing threshold in response to initial delivery of the pacing therapy, determine whether there is a change in the pacing threshold during initial delivery of the pacing therapy, adjust a delivery parameter of the pacing therapy in response to determining whether there is a change in the pacing threshold during initial delivery of the pacing therapy, determine whether there is a decrease in the pacing threshold during delivery of the adjusted pacing therapy, and determine hyperkalemia in response to the decrease in the pacing threshold during delivery of the adjusted pacing therapy being present.

A biostable polymeric substrate of an implantable medical device unit includes a demand-release bioactive composition including one or more bioactive agents covalently bound to surface-modifying end groups of the substrate. Certain cellular activities, in proximity to the polymeric substrate, release substances reacting with the end groups such that the end groups release the one or more bioactive agents, which modify the certain cellular activities.

Demand-release bioactive composition for implantable medical devices

This disclosure describes implantable medical leads that include a lead body and an electrode. A width of the electrode as measured along a longitudinal direction of the lead varies about the perimeter of the lead. The uneven width of the electrode may bias a stimulation field in a particular direction, e.g., a radial or transverse direction relative to the longitudinal axis of the lead. Electrodes with an uneven width may be useful for controlling the direction of propagation of the stimulation field in order to, for example, avoid phrenic nerve stimulation during LV pacing or neck muscle stimulation during vagal neurostimulation.

Implantable medical lead with biased electrode

The preparation and use of medical devices having radiopaque and echogenic materials including coated tungsten and/or tungsten carbide particles are disclosed herein.

Medical devices with encapsulated visibility particles

An elongate medical electrical lead conductor includes a layer of hydrolytically stable polyimide formed thereover.

Implantable medical device conductor insulation and process for forming

Growing community of inventors

Fridley, MN, United States of America

Michael Jay Ebert